Promoting exercise in adults with heart failure with preserved ejection fraction
Official title: HEART (Heart Failure Exercise and Resistance Training) Camp Connect: Promoting Adherence to Exercise in Adults With Heart Failure With Preserved Ejection Fraction
Run by University of Nebraska · NCT05784753 · Data updated 2026-11-12
This study is testing whether different types of exercise coaching can help adults with heart failure feel better and improve their physical health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | University of Nebraska Academic / other |
| Locations | 3 sites (Detroit, Michigan and 2 other locations) |
| Status | Recruiting |
| Started | November 20, 2023 |
| Main results expected | February 2028 |
| Study ends | March 2028 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT05784753 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults diagnosed with HFpEF who are stable on their medications and able to participate in exercise.
✕Probably not a fit
Patients with life-limiting illnesses, unstable heart conditions, or those unable to safely engage in exercise may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to investigate the effects of exercise coaching on adults with heart failure with preserved ejection fraction (HFpEF). Participants will be randomly assigned to one of three groups: one receiving in-person coaching, another using video conferencing for coaching, and a control group with access to exercise videos. Over 18 months, the study will assess exercise adherence, health status improvements, and changes in physical function and inflammatory markers. The study will also evaluate the cost-effectiveness and scalability of the intervention methods.
Why it matters
Potential benefit: If successful, this study could enhance exercise adherence and improve health outcomes for patients with HFpEF.
How similar studies have gone: Other studies have shown positive outcomes with exercise interventions in heart failure populations, suggesting this approach has potential.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of heart failure with an ejection fraction greater than or equal to 50 * Echocardiogram in prior 24 months * Stable pharmacologic therapy in the past 30 days * Any of the following evidence to confirm HFpEF - Score\< 6 on Heavy Hypertensive Atrial Fibrillation, Pulmonary Hypertension, Elder, Filling Pressure algorithm, invasive hemodynamic evidence of HFpEF(i.e., elevated pulmonary wedge pressure), or a confirmed clinical diagnosis of HFpEF Exclusion Criteria: * Life-limiting illness precluding study completion * Clinical evidence of decompensated heart failure * Unstable angina or marked shortness of breath on exertion at less than 2 metabolic equivalents * Myocardial infarction, coronary artery bypass graft, or biventricular pacemaker in prior 6 weeks * Orthopedic or neuromuscular disorders preventing aerobic exercise * Cardiopulmonary exercise test results that preclude safe exercise * Unwilling/unable to complete pre-randomization procedures * Pregnancy * Implantable cardioverter defibrillator
Where it's running
-
Henry Ford Health System
Detroit, Michigan, United States Recruiting -
University of Nebraska Medical Center
Omaha, Nebraska, United States Recruiting -
University of Virginia
Charlottesville, Virginia, United States Not yet recruiting
Study contacts
- Principal investigator: Windy W Alonso, PhD — University of Virginia
- Study coordinator: Windy W Alonso, PhD
- Email: windy.alonso@unmc.edu
- Phone: 402-559-8342
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tamibarotene for HFpEF: see if this drug helps heart failure with preserved ejection fraction
A 12-week trial tests whether tamibarotene can reduce NT-proBNP levels in adults with HFpEF compared with placebo.
-
High-intensity interval training guided by cardiopulmonary exercise testing for HFpEF
This trial tests whether a personalized high-intensity interval training program, guided by CPET results, can help people with heart failure with preserved ejection fraction improve their fitness and symptoms.
-
Finerenone in patients having TAVI with heart failure
This study tests whether finerenone can help people with heart failure and preserved ejection fraction who are undergoing transcatheter aortic valve implantation.
-
Tiny ultrasound bubbles as an alternative to catheters for measuring pressures inside the heart
This will test whether injecting tiny ultrasound bubbles can estimate heart filling pressures in people who are having a cardiac catheterisation.
-
Tailored exercise training for adults with HFpEF
This program will test remote, personalized exercise and lifestyle plans to see if they help adults with HFpEF or at risk of it improve how much they can exercise and their muscle health.
-
US benchmarking of heart and liver stiffness using shear wave ultrasound
This project will test whether a new ultrasound device can measure heart and liver stiffness using shear wave velocity in people aged 60 or older with preserved or mildly reduced ejection fraction and left ventricular hypertrophy, with or without transthyretin amyloid cardiomyopathy, and in control subjects.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.